|
PF-56914 |
CEFALEXINA Balaxi 500 mg Cápsulas |
2024-07-09 |
|
Balaxi Healthcare Guatemala |
India
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56926 |
NISTATINA Balaxi 100,000 UI/ mL Suspención oral |
2024-07-11 |
|
Balaxi Healthcare Guatemala |
India
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57318 |
LEVOFLOXCINO Balaxi 750 mg Tabletas recubiertas |
2024-10-14 |
|
Balaxi Healthcare Guatemala |
India
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51184 |
LUPRODEX 3.75 mg (DEPOT) Polvo liofilizado y solvente para solución inyectable |
2025-03-24 |
|
Bharat Serums and Vaccines Limited. |
India
|
Zomapharma |
Intercare |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51848 |
AMPHONEX 50 mg Liofilizado para uso parenteral |
2025-09-11 |
|
Bharat Serums and Vaccines Limited. |
India
|
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Zomapharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53319 |
ENDOPROST Solución inyectable |
2027-01-06 |
|
Bharat Serums and Vaccines Limited. |
India
|
Medicamentos Avanzados, Sociedad Anónima |
Zomapharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38855 |
THYMOGAM 250 mg/5mL Solución Inyectable |
2028-07-13 |
|
Bharat Serums and Vaccines Limited. |
India
|
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Zomapharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43895 |
AMPHOLIP 50 mg/ 10 mL Suspensión inyectable |
2024-11-03 |
|
Bharat Serums and Vaccines Limited. |
India
|
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Zomapharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46521 |
BSV-HUMOG 75 HP Polvo Liofilizado para Uso Parenteral |
2026-10-22 |
|
Bharat Serums and Vaccines Limited. |
India
|
Intercare |
Zomapharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46546 |
BSV-HUMOG 150 HP Polvo Liofilizado para uso Parenteral |
2026-10-29 |
|
Bharat Serums and Vaccines Limited. |
India
|
Zomapharma |
Intercare |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|